When: Confirmed close above $226.88 with volume ≥5M

Then: Add 20% of intended incremental exposure

HOLD

• MACD reading: 6.934 vs 7.400 signal line (bearish crossover already occurred)
• RSI at 67.68 with mild bearish divergence
• Price at $221.64: 0.6% above 10-day EMA ($220.34), 1.2% above VWMA ($219.01), 2.3% below 52-week high ($226.88)
• Volume of 4.43 million shares below the 5 million shares needed for credible breakout
• MACD histogram deteriorated for three consecutive sessions
• Support at $219.75 and $219.01; close below would be meaningful warning
• Operating cash flow rose to $10.57 billion in 2025
• Free cash flow rose to $7.45 billion in 2025
• Net debt declined to $30.47 billion
• Trailing P/E: 38.95x; Forward P/E: 28.22x; PEG: 2.77x; P/B: 4.5x
• FCF yield approximately 2.5%
• DCF estimate of approximately 3% upside (thin margin of safety)
• Forward EPS $7.85 implies fair value near $219.80 at 28x multiple
• 10% earnings shortfall at same multiple would put fair value near $198
• 50-day SMA at $199.74 provides ~10.9% cushion from current price
• Tomahawk agreement: $22.9 billion over seven years, approximately $3.27 billion annualized (3.5% of trailing revenue)
• Current ratio: 1.01; tangible book value: negative $19.94 billion
• Beta: 0.294 (historical market sensitivity, not price floor)
• 30-year Treasury yield at 19-year high
• 85% market-implied probability of no Fed cuts in 2026
• Bullish sentiment score: 7.2 out of 10 with medium confidence; Reddit data contains no posts
• ATR: $4.65
• Proposed $189 stop is 14.7% from current price (~5.6 ATRs from $215 entry) - too loose for tactical sleeve
• Two-ATR reference: approximately $212.10; three-ATR reference: approximately $207.70
• Conservative entry trigger: reclaim $215.92 Bollinger midpoint and $218.18-$219.01 area with stabilizing MACD histogram
• Breakout tranche: 10%-20% of increment, daily close above $226.88-$227, volume above 5 million shares
• Partial reduction trigger: daily close below $199.74 with RSI below 50 and MACD deterioration
• Eliminate core on sustained close below verified $189.29 200-day SMA
• If already at 2%-3% cap, trim 25%-33% into strength or reduce core toward 1.5%-2%

→ vs aggressive: The $199-$205 target area offering best risk-reward is too optimistic - it could represent a breakdown with deteriorating momentum, RSI below 50, and negative MACD histogram, making it a falling knife without confirmed reversal

→ vs aggressive: The sensitivity analysis assumes multiple expansion to 30-32x forward earnings which is not conservative given 30-year Treasury at 19-year high and tightening financial conditions

→ vs aggressive: The $189 stop is too loose for a tactical addition - a tactical sleeve should not use the same stop as the core position; two-ATR (~$212.10) or three-ATR (~$207.70) references are more appropriate

→ vs aggressive: The bullish MACD crossover claim is factually incorrect - MACD line at 6.934 is already below the signal line at 7.400

→ vs aggressive: The Tomahawk contract's ~$3.27 billion annualized value equals only ~3.5% of trailing revenue and is not guaranteed revenue or profit - capacity constraints could delay revenue or compress margins

→ vs aggressive: Beta of 0.294 is historical market sensitivity, not a guarantee against company-specific losses or a price floor; 19-year high yields and risk-off conditions create credible path to multiple compression

→ vs neutral: The neutral waiting-for-pullback-or-confirmed-breakout position is correct in direction but lacks discipline - should not mean buying automatically at $215-$218 simply because price reaches $199-$205

→ vs aggressive: A 2%-3% position limit is not automatically conservative when paired with a 12%-15% stop; if already at the 2%-3% maximum, should not reserve right to add under proposed schedule

HOLD with modified tiered entry plan; do not trim core position; cap exposure at 2% until conditions met

• Reduce first incremental tranche from 50% to 25% of intended exposure in $215-$218 zone, requiring reclaiming $215.92 Bollinger midpoint and $218-$219 area with MACD histogram showing decelerating negative slope
• Hold 30% allocation at $199-$205 with confirmation requirements: 50 SMA hold, RSI recovering above 50, and positive MACD histogram turn
• Hold 20% breakout tranche above $226.88 with volume above 5 million shares and at least one day of follow-through
• Tactical stop around $212 (approximately 2x ATR from $221.64) for incremental tranches; $189 reserved as regime-level core invalidation
• Total portfolio exposure capped at 2% until confirmed breakout above $226 or successful 50 SMA retest with momentum recovery; 3% ceiling only after one condition met
• Do not trim core position—structural thesis intact with multi-year catalysts (Tomahawk contract, interceptor framework, FCF inflection)
• At 28x on $7.85 EPS fair value is $219.80, essentially current price; upside case requires multiple expansion in hostile macro environment
• MACD has confirmed bearish crossover with three consecutive negative histogram bars—a yellow flag that deserves more analytical weight
• Geopolitical premium and defense-sector defensive characteristics are valid but insufficient to overcome macro headwinds without confirmation signals
• Sentiment score 7.2 out of 10 with bullish institutional endorsement means selling into this tape is fighting the flow

→ vs aggressive: MACD crossover deserves more weight than being used merely to justify HOLD; it should inform sizing and entry triggers, not just inaction

→ vs aggressive: Valuation sensitivity using 30x and 32x multiples is too generous—at 28x, $7.85 EPS yields $219.80 (essentially current price), and at 25x yields $196.25 (below 50 SMA)

→ vs aggressive: 0.6% above 10-day EMA is essentially a test, not cushion—18 cents is not a margin of safety; the 50 SMA at $199.74 and 200 SMA at $189.29 are the real structural references

→ vs aggressive: $199-$205 zone framed as 'attractive tactical risk-reward' is conditional, not high-conviction—with bearish MACD and RSI cooling, probability of clean V-shape bounce is meaningfully lower

→ vs conservative: 25-33% core trim is too aggressive—RTX is 17.1% above 200-day SMA in confirmed Golden Cross regime with multi-year catalyst visibility; trimming quality defense into structural uptrend is overcorrecting

→ vs conservative: Downside scenario is too pessimistic—defense primes typically get multiple expansion during earnings misses, not compression; 10% EPS miss at 32x gives $226, not $198

→ vs conservative: 'Wait for MACD histogram to stabilize' rule is too late—by the time histogram stabilizes, price has already moved; right discipline is adding on pullback with decelerating histogram slope, not waiting for full recovery